11
Participants
Start Date
February 28, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Capecitabine
Initial dose of 750-1500 mg/m\^2 orally twice a day for each 21 day cycle.
Celecoxib
200 mg given orally twice a day for each 21 day cycle.
Radiation Therapy
Some patients may undergo radiation therapy 5 days a week for 5-6 weeks, and receive oral capecitabine twice daily 5 days a week. Following completion of radiotherapy, patients may continue oral capecitabine once daily on days 1-14.
Placebo
Oral placebo twice daily on days 1-21
CCOP - Main Line Health, Wynnewood
CCOP - Greenville, Greenville
CCOP - Columbus, Columbus
CCOP - Grand Rapids, Grand Rapids
Marshfield Clinic - Marshfield Center, Marshfield
CCOP - Kansas City, Kansas City
Cancer Research for the Ozarks, Springfield
Scott and White Cancer Institute, Temple
CCOP - Santa Rosa Memorial Hospital, Santa Rosa
CCOP - Kalamazoo, Kalamazoo
Hematology Oncology Associates of Central New York, PC - Northeast Center, East Syracuse
M. D. Anderson Cancer Center at University of Texas, Houston
CCOP - Northwest, Tacoma
MBCCOP - San Juan, San Juan
Collaborators (1)
National Cancer Institute (NCI)
NIH
Pfizer
INDUSTRY
M.D. Anderson Cancer Center
OTHER